TICKER INTELLIGENCE

$EXAS

Federal money vs revenue, lobbying and PAC giving →

NYSE/NASDAQ: EXAS

Washington Intelligence

Active Bills

Gov't Contracts

Congressional Trades

$EXAS is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $EXAS, including 1 bill. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.

Congressional Trades in $EXAS

25 filings

Kevin HernR-OK

SELL $1,001 - $15,000 — Exact Sciences Corporation - Common Stock (EXAS)

2026-04-03

Josh GottheimerD-NJ

SELL $1,001 - $15,000 — Exact Sciences Corporation - Common Stock (EXAS) [ST]

2024-06-08

Josh GottheimerD-NJ

SELL $1,001 - $15,000 — Exact Sciences Corporation - Common Stock (EXAS)

2024-03-07

Related Sectors

Healthcare

Congressional Legislation Affecting $EXAS

Triple-Negative Breast Cancer Research and Education Act of 2025

NEUTRAL

HR1806 is a procedural, early-stage House bill that directs federal research and education efforts for triple-negative breast cancer but authorizes no specific funding, creates no procurement programs, and imposes no mandates on public companies. It has zero immediate market impact.

HR1806Mar 3, 2025

Understanding These Signals

What is a Signal?Market Sentiment Federal Contracts Full Glossary →

Get Full Access to $EXAS Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →